SCHEMBL6837596

SCHEMBL6837596

CNCc1ccc(OC)c2oc(C(=O)N3CCOCC3)cc12

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 3/20 0.51
ADRA2B P18089 3/20 0.51
ADRA2C P18825 3/20 0.51
KMT2A Q03164 3/20 0.46
HTT P42858 1/20 0.46
GLA P06280 1/20 0.46
ALDH1A1 P00352 1/20 0.46
NPC1 O15118 2/20 0.44
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
RXFP1 Q9HBX9 1/20 0.42
HPGD P15428 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PRKCZ Q05513 1/20 0.42
GAA P10253 1/20 0.42
MEN1 O00255 1/20 0.42
RAB9A P51151 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833406 0.92 ADRA2A (0.56) ADRA2AADRA2BADRA2CKMT2AALDH1A1
SCHEMBL6833377 0.91 ADRA2A (0.55) ADRA2AADRA2BADRA2CALDH1A1NPC1
SCHEMBL6837770 0.91 ADRA2A (0.49) ADRA2AADRA2BADRA2CKMT2AHTT
SCHEMBL6836425 0.90 ADRA2A (0.50) ADRA2AADRA2BADRA2CKMT2AHTT
SCHEMBL6836666 0.89 ADRA2A (0.57) ADRA2AADRA2BADRA2CKMT2AHTT
SCHEMBL6836426 0.89 ADRA2A (0.47) ADRA2AADRA2BADRA2CKMT2AHTT
SCHEMBL6837950 0.88 ADRA2A (0.47) ADRA2AADRA2BADRA2CKMT2AHTT
SCHEMBL6837784 0.87 LMNA (0.47) ADRA2AADRA2BADRA2CKMT2AHTT
SCHEMBL6837532 0.87 ADRA2A (0.52) ADRA2AADRA2BADRA2CKMT2AHTT
SCHEMBL6833276 0.86 ADRA2A (0.59) ADRA2AADRA2BADRA2CKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 ADRA2A 1965/4885ADRA2B 1631/4885ADRA2C 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.